- Home
- IPW vs BRNS Comparison
IPW vs BRNS Comparison
Compare IPW & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPW
- BRNS
- Stock Information
- Founded
- IPW 2018
- BRNS 2016
- Country
- IPW United States
- BRNS United Kingdom
- Employees
- IPW N/A
- BRNS N/A
- Industry
- IPW Catalog/Specialty Distribution
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- IPW Consumer Discretionary
- BRNS Health Care
- Exchange
- IPW Nasdaq
- BRNS Nasdaq
- Market Cap
- IPW 19.8M
- BRNS 48.3M
- IPO Year
- IPW 2021
- BRNS 2021
- Fundamental
- Price
- IPW $0.54
- BRNS $1.09
- Analyst Decision
- IPW
- BRNS Strong Buy
- Analyst Count
- IPW 0
- BRNS 1
- Target Price
- IPW N/A
- BRNS $3.00
- AVG Volume (30 Days)
- IPW 129.8K
- BRNS 37.9K
- Earning Date
- IPW 11-13-2025
- BRNS 11-05-2025
- Dividend Yield
- IPW N/A
- BRNS N/A
- EPS Growth
- IPW N/A
- BRNS N/A
- EPS
- IPW N/A
- BRNS N/A
- Revenue
- IPW $74,105,251.00
- BRNS $14,969,000.00
- Revenue This Year
- IPW $8.31
- BRNS N/A
- Revenue Next Year
- IPW $77.15
- BRNS N/A
- P/E Ratio
- IPW N/A
- BRNS N/A
- Revenue Growth
- IPW N/A
- BRNS 1766.46
- 52 Week Low
- IPW $0.41
- BRNS $0.64
- 52 Week High
- IPW $2.36
- BRNS $2.92
- Technical
- Relative Strength Index (RSI)
- IPW 48.05
- BRNS 42.23
- Support Level
- IPW $0.49
- BRNS $1.08
- Resistance Level
- IPW $0.55
- BRNS $1.20
- Average True Range (ATR)
- IPW 0.04
- BRNS 0.09
- MACD
- IPW 0.00
- BRNS -0.01
- Stochastic Oscillator
- IPW 47.06
- BRNS 3.74
About IPW iPower Inc.
iPower Inc is online hydroponic equipment and accessory retailer and supplier in North America. The company sells products through own website as well as online channel partners that include Amazon, Walmart, and eBay.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.